Want to learn more about PixCell? No problem - fill in your details below and our team will be in touch!
We appreciate you contacting us. One of our
colleagues will get back in touch with you soon!Have
a great day!
Of the 850,000 cases of sepsis diagnosed annually, as many as 80% start receiving treatment in the emergency department. Early detection and treatment may prevent progression to severe sepsis or septic shock while reducing the number of ICU admissions related to the dangerous bacterial bloodstream infection.
The HemoScreen from PixCell Medical leverages a revolutionary cartridge design that facilitates running a test near the patient providing on-the-spot results. Furthermore, it requires just a few microliters of blood and its operation is fully automatic once the cartridge is inserted into the device. It will rapidly detect disease markers for sepsis in a complete blood (CBC) panel with a 5-part differential.
Implementing HemoScreen in the ED alleviates operational strains on resources. It also provides opportunities to improve patient care and other quality metrics like LOS and LWBS. Better ratings from quality surveys and inspections can benefit a facility’s reimbursement rate, accreditation status, and access to resources.
Laboratories associated with larger emergency departments and hospitals will run hundreds of thousands of tests each month and analyze more than 300,000 CBC panels with and without differentials annually.
Sepsis medical devices that can provide quick, accurate results are crucial for early sepsis detection. Slow devices that cannot keep up with the number of tests to be performed can quickly bottleneck processes, leading to extended LOS and reduced quality of patient care.
HemoScreen analyzes 20 different parameters using innovative machine vision technology and algorithms. The streamlined cartridge design starts running automatically once inserted into the device and produces results in about 5 minutes. Physicians get rapid, accurate information and can make life-saving clinical decisions at the bedside without waiting on results from the lab.
The system will identify and flag abnormalities that indicate sepsis, including:
HemoScreen is the only FDA-approved portable point-of-care blood testing device. Its compact footprint and factory-calibrated cartridges make it uniquely suited for emergency medical transport.
This level of portability and accessibility in a sepsis medical device is only possible with PixCell Medical’s revolutionary equipment. No external reagents or calibration are needed, so samples collected from patients in ambulances or med-evac helicopters can be easily analyzed en route to the emergency room.
Critical results can be called in ahead of time or presented to physicians immediately upon arrival, allowing for the earliest possible sepsis detection.
PixCell Medical’s HemoScreen platform is ideal for any emergency department, even those with in-house labs. Here’s how HemoScreen compares to traditional lab technology.
Downtime on laboratory equipment is costly and directly affects patient care, quality measures, and the bottom line.
HemoScreen’s pre-calibrated, disposable cartridges allow for effortless troubleshooting and re-testing. Input the sample into a new cartridge and insert it into the device, and the device will automatically initiate the analysis. Results are only a few minutes away without further disruption to patient care.
Restrictions on who can use the sepsis medical devices in a department can create bottlenecks, delay diagnosis and treatment times, and cause other logistical issues.
HemoScreen is registered as a moderately complex CLIA device. An array of medical personnel are eligible for the required level of training, such as:
After initial training and a six-month review, staff should complete annual refresher training on the device to ensure continued competency, reimbursement, and patient safety practices. Training and sign-off can easily be incorporated into a facility’s internal education management system.
HemoScreen from PixCell Medical minimizes maintenance and quality control processes.
Typical analysis devices in laboratories require multiple daily quality checks. As an IQCP-eligible device, quality control requirements for HemoScreen are reduced to every 30 days.
HemoScreen cartridges are calibrated at the factory and contain all the reagents and chemicals needed to run the analysis. Used cartridges are simply discarded–no need to clean the machine before running another test.
This unique system eliminates the need for regular calibration and preventative maintenance schedules, which cost departments time, money, and resources whenever a machine is being serviced.
Point-of-care testing has never been more accessible while maintaining clinical reliability to such a wide range of applications within the healthcare industry. HemoScreen is portable, efficient, and produces validated, lab-quality results within minutes. We’re transforming blood testing for medical professionals everywhere, allowing for earlier sepsis detection, smoother department operations, and enhanced patient care overall.
Contact PixCell Medical for more information and to request a HemoScreen demo today!
(*) Please note: training must be defined by local, state and federal regulations. In the USA, training is defined for CLIA moderate complexity devices.
